Jane Street’s Cardiff Oncology CRDF Stock Holding History

Jane Street’s Portfolio CRDF Stock Details CRDF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,500	Closed	-$21.6K	–	11293
2025 Q3	$21.6K	Buy	+10,500	New	+$29K	﹤0.01%	10521
2021 Q4	–	Sell	-35,400	Closed	-$236K	–	10149
2021 Q3	$236K	Buy	35,400 +21,400	+153%	+$134K	﹤0.01%	8611
2021 Q2	$93K	Buy	+14,000	New	+$119K	﹤0.01%	9295
2021 Q1	–	Sell	-17,300	Closed	-$311K	–	9143
2020 Q4	$311K	Sell	17,300 -28,600	-62%	-$503K	﹤0.01%	6346
2020 Q3	$651K	Buy	+45,900	New	+$303K	﹤0.01%	4763

Other funds holding CRDF

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

FLPIM

F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return

Jane Street's CRDF Position: Q1 2026 in Review

Jane Street reduced its Cardiff Oncology (CRDF) stake by 70% in Q1 2026, selling an estimated $190K and leaving 40,105 shares worth $65K. The position accounts for ﹤0.01% of the portfolio, ranked #10869.

Jane Street first reported a position in CRDF in Q4 2016 and has held it in 14 quarters since. The position peaked at $386K in Q1 2024. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.

Jane Street held 40,105 shares of Cardiff Oncology worth $65K as of Q1 2026.
Jane Street sold 92,745 Cardiff Oncology shares in Q1 2026, an estimated $190K.
Cardiff Oncology made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10869 holding.
Jane Street first reported a position in Cardiff Oncology in Q4 2016 and has held it in 14 quarters since.
Jane Street's Cardiff Oncology position peaked at $386K in Q1 2024.
116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.